for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Shanghai Pharmaceuticals Holding Co Ltd

601607.SS

Latest Trade

20.30CNY

Change

0.02(+0.10%)

Volume

13,477,186

Today's Range

20.25

 - 

20.56

52 Week Range

17.29

 - 

25.98

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
20.28
Open
20.34
Volume
13,477,186
3M AVG Volume
229.68
Today's High
20.56
Today's Low
20.25
52 Week High
25.98
52 Week Low
17.29
Shares Out (MIL)
2,842.09
Market Cap (MIL)
50,454.14
Forward P/E
10.70
Dividend (Yield %)
2.22

Next Event

Q1 2021 Shanghai Pharmaceuticals Holding Co Ltd Earnings Release

Latest Developments

More

Shanghai Pharma's 2020 Net Profit Up 10.2% Y/Y, Plans Bond Issue

Shanghai Pharmaceuticals Sets Aside Provision For Impairment Of Goodwill

Shanghai Pharma Says SPH Health Commerce Raises Registered Capital To 2.0 Bln Yuan After Taking In Seven Investors

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Shanghai Pharmaceuticals Holding Co Ltd

Shanghai Pharmaceuticals Holding Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceuticals. The Company's businesses include the research and registration, production, sales, distribution and retailing of pharmaceutical products, among others. Its products are applied in cardiovascular system, anti-cancer and immunoregulation, anti-infection and metabolism, as well as other fields. The Company operates businesses in domestic and overseas markets.

Industry

Major Drugs

Contact Info

Shanghai Pharmaceutical Mansion

No.200 Taicang Road

SHANGHAI, SHA

200020

China

+86.21.63730908

http://www.sphchina.com/

Executive Leadership

Jun Zhou

Chairman of the Board, Non-Executive Director

Min Zuo

President, Executive Director

Dawei Ge

Vice Chairman of the Board, Non-Executive Director

Bo Shen

Chief Financial Officer, Vice President, Executive Director

Yongzhong Li

Vice President, Executive Director

Key Stats

2.08 mean rating - 13 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2018

159.1K

2019

186.6K

2020

191.9K

2021(E)

222.1K
EPS (CNY)

2018

1.372

2019

1.440

2020

1.580

2021(E)

1.851
Price To Earnings (TTM)
12.53
Price To Sales (TTM)
0.26
Price To Book (MRQ)
1.24
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
91.69
LT Debt To Equity (MRQ)
5.92
Return on Investment (TTM)
10.54
Return on Equity (TTM)
3.92

Latest News

Latest News

BRIEF-Shanghai Pharmaceuticals Plans To Set Up JV

* SAYS IT PLANS TO SET UP JV WITH REGISTERED CAPITAL OF 500 MILLION YUAN ($72.85 million) WITH PARTNER Source text in Chinese: https://bit.ly/34Kt1Zx Further company coverage: ($1 = 6.8636 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Shanghai Pharmaceuticals' Affiliate To Receive Property Compensation Of 2.0 Bln Yuan

* SAYS ITS AFFILIATE TO RECEIVE PROPERTY COMPENSATION OF 2.0 BILLION YUAN ($281.44 million) Source text in Chinese: https://bit.ly/2WzCFKc Further company coverage: ($1 = 7.1062 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Shanghai Pharmaceuticals Announces Entering Into Land Acquisition And Reserve Agreement

* CHIATAI QINGCHUNBAO & WEST STREAM VALLEY CONSTRUCTION HEADQUARTER ENTER LAND ACQUISITION & RESERVE AGREEMENT

BRIEF-Shanghai Pharmaceuticals To Issue Up To 8 Bln Yuan Worth Of Bonds

* SAYS IT PLANS TO ISSUE UP TO 8.0 BILLION YUAN ($1.13 billion) WORTH OF BONDS Source text in Chinese: https://bit.ly/3btGTHJ Further company coverage: ($1 = 7.0916 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Shanghai Pharmaceuticals Gets Approval To Issue Commercial Paper Worth 5.0 Bln Yuan

* SAYS IT GETS APPROVAL TO ISSUE COMMERCIAL PAPER WORTH 5.0 BILLION YUAN ($716.30 million) Source text in Chinese: https://bit.ly/2u3BGGw Further company coverage: ($1 = 6.9803 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up